Product information

From Health Canada

Current status:

Approved

Current status date:

2023-04-18

Product name:

FINLIUS I.V.

Description:

SINGLE-USE VIAL

DIN:

02537311 Electronic product monograph is not available

Company:

JANSSEN INC
19 Green Belt Drive
Toronto
Ontario
Canada M3C 1L9

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Prescription ,  Schedule D

 

American Hospital Formulary Service (AHFS): See footnote 3

92:20.00  ,  84:92.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

L04AC05 USTEKINUMAB

Active ingredient group (AIG) number:See footnote5

0152506002

List of active ingredient(s)
Active ingredient(s) Strength
USTEKINUMAB 5 MG / ML
Version 4.0.2
Date modified: